Covid-19 roundup: Sh­iono­gi vac­cine proves ef­fec­tive — re­port; Eli Lil­ly, In­cyte's JAK re­duces death, study finds

As the fam­i­ly of pro­tein-based Covid-19 vac­cines con­tin­ues to push for­ward, one com­pa­ny has re­port­ed­ly found its shot to be safe and ef­fec­tive.

Japan’s Sh­iono­gi said ear­ly Fri­day its vac­cine met the pri­ma­ry end­point in a Phase II/III study eval­u­at­ing it as a boost­er shot, Bloomberg re­port­ed. There were no se­ri­ous side ef­fects or deaths re­lat­ed to the vac­cine.

The news comes at a time when Japan has seen a slow boost­er up­take, de­spite hav­ing one of the high­est two-shot im­mu­niza­tion rates among wealthy coun­tries. Rough­ly 21% of the Japan­ese pop­u­la­tion has re­ceived a boost­er, Bloomberg re­port­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER